Patents by Inventor Fumihito HOSOI

Fumihito HOSOI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preventive and/or therapeutic agent of immune disease
    Patent number: 9782412
    Abstract: Provided is a preventive and/or therapeutic agent for immune diseases containing a compound having a BTK inhibitory activity or a salt thereof, as an active ingredient. A preventive and/or therapeutic agent of immune diseases, comprising a compound represented by Formula (I), where R1 to R3, W, X, Y, Z, and n represent those as defined in the specification, or a salt thereof, as an active ingredient.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: October 10, 2017
    Assignee: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Fumihito Hosoi, Yoshinori Nakachi, Daisuke Kajiwara
  • Fused pyrimidine compound or salt thereof
    Patent number: 9580432
    Abstract: Provided is a novel compound having BTK inhibitory action and a cell proliferation suppressing effect. Also provided is a medicine useful for the prevention and/or treatment of a disease associated with BTK, particularly cancer, based on BTK inhibitory action. A compound represented by formula (I) [wherein R1 to R3, W, A, Y and Z respectively have the meanings as defined in the specification], or a salt thereof is disclosed.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: February 28, 2017
    Assignee: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Satoru Iguchi, Fumihito Hosoi, Takeshi Sagara
  • PREVENTIVE AND/OR THERAPEUTIC AGENT OF IMMUNE DISEASE
    Publication number: 20170042900
    Abstract: Provided is a preventive and/or therapeutic agent for immune diseases containing a compound having a BTK inhibitory activity or a salt thereof, as an active ingredient. A preventive and/or therapeutic agent of immune diseases, comprising a compound represented by Formula (I), where R1 to R3, W, X, Y, Z, and n represent those as defined in the specification, or a salt thereof, as an active ingredient.
    Type: Application
    Filed: October 19, 2016
    Publication date: February 16, 2017
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Fumihito HOSOI, Yoshinori Nakachi, Daisuke Kajiwara
  • NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF
    Publication number: 20160115168
    Abstract: Provided is a novel compound having BTK inhibitory action and a cell proliferation suppressing effect. Also provided is a medicine useful for the prevention and/or treatment of a disease associated with BTK, particularly cancer, based on BTK inhibitory action. A compound represented by formula (I) [wherein R1 to R3, W, A, Y and Z respectively have the meanings as defined in the specification], or a salt thereof is disclosed.
    Type: Application
    Filed: August 11, 2014
    Publication date: April 28, 2016
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Satoru IGUCHI, Fumihito HOSOI, Takeshi SAGARA